Literature DB >> 8628001

Comparison between the in vitro intrinsic radiation sensitivity of human soft tissue sarcoma and breast cancer cell lines.

W Ruka1, A Taghian, D Gioioso, J A Fletcher, F Preffer, H D Suit.   

Abstract

The purpose of this study is to evaluate the radiation sensitivity of human soft tissue sarcoma cell lines in vitro and to compare with that of human breast carcinoma and glioblastoma cell lines. The intrinsic radiation sensitivity parameters of seven human soft tissue sarcomas and eight breast carcinoma cell lines were investigated in vitro by clonogenic assays for single-dose irradiation under aerobic conditions on cells in exponential phase of growth. The results for sarcoma cell lines showed that the mean surviving fraction at 2 Gy (SF2) was 0.39 (SD +/- 0.09) with a range of 0.24 to 0.53, and the average mean inactivation dose (MID) was 1.92 (SD +/- 0.35) range from 1.36 Gy to 2.49 Gy. These values were not different from that of breast cell lines examined concurrently and using the same experimental methods (mean SF2 0.38, SD +/- 0.09; MID 1.9 Gy, SD +/- 0.37). However radiobiological parameters of nine karyotyped human malignant glioma cell lines determined earlier in this laboratory were significantly higher (mean SF2 0.50 +/- 0.14; mean MID 2.61 +/- 0.60). In conclusion, the data presented here do not support the view that cells of sarcomas show unusual radiation resistance. To the extent that the in vitro determined cellular radiation sensitivity reflects the tumor response in vivo, the success rate for radiation applied against sarcoma and breast carcinoma of comparable size could be similar.

Entities:  

Mesh:

Year:  1996        PMID: 8628001     DOI: 10.1002/(SICI)1096-9098(199604)61:4<290::AID-JSO13>3.0.CO;2-A

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  7 in total

1.  [Soft tissue carcinoma. Epidemiology, diagnostics and therapy].

Authors:  H Rechl; K Wörtler; G Weirich; K Specht; R Gradinger
Journal:  Orthopade       Date:  2006-12       Impact factor: 1.087

2.  Molecular type and maximal metastasis diameter influence risk of axillary recurrence in breast cancer patients after positive sentinel lymph node biopsy.

Authors:  Michał Falco; Bartłomiej Masojć; Andrzej Kram
Journal:  Rep Pract Oncol Radiother       Date:  2021-09-30

3.  Preoperative radiotherapy for adult head and neck soft tissue sarcoma: assessment of wound complication rates and cancer outcome in a prospective series.

Authors:  Brian O'Sullivan; Patrick Gullane; Jonathan Irish; Peter Neligan; Fred Gentili; James Mahoney; Susanna Sellmann; Charles Catton; John Waldron; Dale Brown; Ian Witterick; Jeremy Freeman; Robert Bell
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

Review 4.  Optimizing radiation therapy and post-treatment function in the management of extremity soft tissue sarcoma.

Authors:  Thomas F DeLaney
Journal:  Curr Treat Options Oncol       Date:  2004-12

5.  Solitary Fibrous Tumors of Chest: Another Look with the Oncologic Perspective.

Authors:  Mert Saynak; Nirmal K Veeramachaneni; Jessica L Hubbs; Dilruba Okumuş; Lawrence B Marks
Journal:  Balkan Med J       Date:  2017-04-06       Impact factor: 2.021

6.  Differential Radiosensitizing Effect of 50 nm Gold Nanoparticles in Two Cancer Cell Lines.

Authors:  Miguel Ángel Pérez-Amor; Leonardo Barrios; Gemma Armengol; Joan Francesc Barquinero
Journal:  Biology (Basel)       Date:  2022-08-09

7.  Patterns of Practice Survey: Radiotherapy for Soft Tissue Sarcoma of the Extremities.

Authors:  Chan-Kyung J Cho; Charles Catton; Caroline L Holloway; Karen Goddard
Journal:  Cureus       Date:  2019-11-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.